title: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
abstract: BACKGROUND
  A gene on chromosome 9p, p16INK4, has been implicated in the pathogenesis of cutaneous malignant melanoma in 19 melanoma-prone families. In 10 of these kindreds mutations that impaired the function of the p16INK4 protein (p16M alleles) cosegregated with the disease. By contrast, in the other nine kindreds the mutation did not alter the function of p16INK4 (p16W alleles). We looked for differences in clinical and genetic epidemiologic features in these two groups of families.
  
  
  METHODS
  We compared the median ages at diagnosis of melanoma, number of melanomas, thickness of the tumors, and number of nevi in the kindreds. We estimated prospectively the risks of melanoma or other cancers in families followed for 6 to 18 years and the risks of other cancers since 1925 (the entire period) by comparing the number of cancer cases observed with the number expected.
  
  
  RESULTS
  The risk of invasive melanoma was increased by a factor of 75 in kindreds with p16M alleles and a factor of 38 in kindreds with p16W alleles. Although this difference was not significant (P = 0.14), there was a striking difference in the risk of other tumors. In kindreds with p16M alleles, the risk of pancreatic cancer was increased by a factor of 13 in the prospective period (2 cases observed, 0.15 expected; standardized incidence ratio, 13.1; 95 percent confidence interval, 1.5 to 47.4) and by a factor of 22 in the entire period (7 cases observed, 0.32 expected; standardized incidence ratio, 21.8; 95 percent confidence interval, 8.7 to 44.8). In contrast, we found no cases of pancreatic cancer in kindred with p16W alleles.
  
  
  CONCLUSIONS
  The development of pancreatic cancer in kindreds prone to melanoma may require a p16M mutation. Genetic factors, such as the kind of mutation found in p16INK4, may explain the inconsistent occurrence of other cancers in these kindreds.
authors.affiliation: Genetic Epidemiology Branch, National Cancer Institute, Bethesda, Md, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Goldstein
authors.forename: M C
authors.initials: MC
authors.lastname: Fraser
authors.forename: J P
authors.initials: JP
authors.lastname: Struewing
authors.forename: C J
authors.initials: CJ
authors.lastname: Hussussian
authors.forename: K
authors.initials: K
authors.lastname: Ranade
authors.forename: D P
authors.initials: DP
authors.lastname: Zametkin
authors.forename: L S
authors.initials: LS
authors.lastname: Fontaine
authors.forename: S M
authors.initials: SM
authors.lastname: Organic
authors.forename: N C
authors.initials: NC
authors.lastname: Dracopoli
authors.forename: W H
authors.initials: WH
authors.lastname: Clark
mesh_terms: D000328:Adult; D000483:Alleles; D002899:Chromosomes, Human, Pair 9; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D009154:Mutation; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics; D010190:Pancreatic Neoplasms / Q000235:genetics*; D010375:Pedigree; D011446:Prospective Studies; D012306:Risk; D012878:Skin Neoplasms / Q000235:genetics*